Type your tag names separated by a space and hit enter

Endocarditis, Infective

Endocarditis, Infective is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

  • An infection of the valvular (primarily) and/or mural (rarely) endocardium
  • System(s) affected: cardiovascular, endocrine/metabolic, hematologic/lymphatic, immunologic, pulmonary, renal/urologic, skin/exocrine, neurologic
  • Synonym(s): bacterial endocarditis; subacute bacterial endocarditis (SBE); acute bacterial endocarditis (ABE)

Epidemiology

Incidence
  • Incidence rose in the United States between 2000 and 2011 from 11 per 100,000 to 15 per 100,000
  • 1.5–3% incidence 1 year after prosthetic valve replacement; 3–6% 5 years postreplacement
  • Increasing incidence of cardiovascular device-related infections due to higher frequency of implantable devices, especially in the elderly

Etiology and Pathophysiology

  • ABE: Staphylococcus aureus; Streptococcus groups A, B, C, G; Streptococcus pneumoniae; Staphylococcus lugdunensis; Enterococcus spp. (gram-positive); Haemophilus influenzae or parainfluenzae; Neisseria gonorrhoeae (gram-negative)
  • SBE: α-hemolytic streptococci (viridans group strep), Streptococcus bovis, Enterococcus spp., S. aureus, Staphylococcus epidermidis (gram-positive); HACEK organisms: Haemophilus aphrophilus or paraphrophilus, Actinobacillus (Aggregatibacter) actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Kingella kingae
  • Endocarditis in IV drug abusers (tricuspid valve): S. aureus, Enterococcus spp. (gram-positive); Pseudomonas aeruginosa, Burkholderia cepacia, other bacilli (gram-negative); Candida spp.
  • Early prosthetic valve endocarditis (<60 days after valve implantation): S. aureus, S. epidermidis (gram-positive); gram-negative bacilli; fungi: Candida spp., Aspergillus spp.
  • Late prosthetic valve endocarditis (>60 days after valve implantation): α-hemolytic streptococci, Enterococcus spp., S. epidermidis (gram-positive); Candida spp., Aspergillus spp.
  • Culture-negative endocarditis: 10% of cases; Bartonella quintana (homeless); Brucella spp., fungi, Coxiella burnetii (Q fever), Chlamydia trachomatis, Chlamydophila psittaci, HACEK organisms; Abiotrophia (formerly vitamin B6-deficient streptococci); use of antibiotics prior to blood cultures
  • Device-related endocarditis: coagulase-negative staphylococci or S. aureus

Risk Factors

  • Injection drug use, IV catheterization, certain malignancies (colon cancer), poor dentition, chronic hemodialysis
  • High-risk with:
    • Prosthetic cardiac valve, implantable devices (pacemaker, automatic implantable cardioverter defibrillator [AICD]), total parenteral nutrition
    • Previous infective endocarditis (IE)
    • Congenital heart disease (CHD): unrepaired cyanotic CHD, including palliative shunts and conduits; repaired CHD with prosthetic device during the first 6 months; repaired CHD with residual defects at or near prosthetic site; cardiac transplant with valvulopathy (1)[B]

General Prevention

  • Good oral hygiene.
  • Antibiotic prophylaxis is only recommended for high-risk cardiac conditions (1)[B]—prosthetic heart valve, history of endocarditis, transplant with abnormal valvular function, CHD (see “Risk Factors”).
  • Procedures requiring prophylaxis
    • Oral/upper respiratory tract: any manipulation of gingival tissue or periapical region of teeth or perforation of the oral mucosa (1)[B]; invasive respiratory procedures involving incision; or biopsy of the respiratory mucosa merit prophylaxis. Amoxicillin 2 g PO (if penicillin allergic, clindamycin 600 mg PO) 30 to 60 minutes before procedure or ampicillin 2 g IV/IM are first-line prophylactic choices. For penicillin-allergic patients, use clindamycin 600 mg IV, or cephalexin 2 g PO, or azithromycin/clarithromycin 500 mg PO, or cefazolin/ceftriaxone 1 g IV/IM 30 minutes before procedure. Pediatric doses are amoxicillin 50 mg/kg PO (max 2 g), cephalexin 50 mg/kg PO (max 2 g), clindamycin 20 mg/kg PO (max 600 mg), and ampicillin or ceftriaxone 50 mg/kg (maximum 1 g) IM/IV.
    • GI/GU: Only consider coverage for Enterococcus (with penicillin, ampicillin, piperacillin, or vancomycin) for patients with an established infection undergoing procedures (1)[B].
    • Cardiac valvular surgery or placement of prosthetic intracardiac/intravascular materials: perioperative cefazolin 1 to 2 g IV 30 minutes preop or vancomycin 15 mg/kg (maximum 1 g) (penicillin-allergic patients) 60 minutes preop (1)[B]
    • Skin: incision and drainage of infected tissue; use agents active against skin pathogens (e.g., cefazolin 1 to 2 g IV q8h or vancomycin 15 mg/kg q12h; max 1 g) if penicillin-allergic or if methicillin-resistant S. aureus (MRSA) suspected.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Stephens, Mark B., et al., editors. "Endocarditis, Infective." 5-Minute Clinical Consult, 27th ed., Wolters Kluwer, 2019. Medicine Central, im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/117535/all/Endocarditis__Infective.
Endocarditis, Infective. In: Stephens MB, Golding J, Baldor RA, et al, eds. 5-Minute Clinical Consult. 27th ed. Wolters Kluwer; 2019. https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/117535/all/Endocarditis__Infective. Accessed April 21, 2019.
Endocarditis, Infective. (2019). In Stephens, M. B., Golding, J., Baldor, R. A., & Domino, F. J. (Eds.), 5-Minute Clinical Consult. Available from https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/117535/all/Endocarditis__Infective
Endocarditis, Infective [Internet]. In: Stephens MB, Golding J, Baldor RA, Domino FJ, editors. 5-Minute Clinical Consult. Wolters Kluwer; 2019. [cited 2019 April 21]. Available from: https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/117535/all/Endocarditis__Infective.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Endocarditis, Infective ID - 117535 ED - Stephens,Mark B, ED - Golding,Jeremy, ED - Baldor,Robert A, ED - Domino,Frank J, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/117535/all/Endocarditis__Infective PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -